LENZ Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Olsson Shawn | Chief Commercial Officer | Sale | 5,788 | $26.37 | $152,630 | 4,733 | Nov 17, 2025 |
| MCCOLLUM JAMES W | — | Purchase | 10,500 | $22.79 | $239,295 | 10,500 | Nov 7, 2025 |
| Chevallard Daniel R. | Chief Financial Officer | Purchase | 20 | $22.71 | $454 | 3,208 | Nov 7, 2025 |
| Versant Vantage II GP-GP, LLC | — | Sale | 123 | $47.01 | $5,782 | 764,127 | Sep 30, 2025 |
| Versant Venture Capital VI, L.P. | — | Sale | 40,907 | $43.00 | $1,759,001 | 1,183,811 | Sep 18, 2025 |
| Versant Ventures VII GP, L.P. | — | Sale | 10,076 | $40.03 | $403,342 | 952,802 | Aug 26, 2025 |
| Versant Venture Capital VI, L.P. | — | Sale | 145,051 | $39.50 | $5,729,515 | 1,430,848 | Aug 15, 2025 |
| Versant Ventures VII GP-GP, LLC | — | Sale | 191,376 | $34.00 | $6,506,784 | 1,575,899 | Jul 10, 2025 |
| Versant Vantage II GP-GP, LLC | — | Sale | 200,000 | $30.47 | $6,094,000 | 1,767,275 | Jun 27, 2025 |
| Versant Ventures VI GP, L.P. | — | Sale | 133,924 | $30.25 | $4,051,201 | 1,967,275 | Jun 20, 2025 |
| Versant Vantage II GP-GP, LLC | — | Sale | 350,000 | $29.00 | $10,150,000 | 1,248,789 | Jun 10, 2025 |
| Olsson Shawn | Chief Commercial Officer | Option Exercise | 1,400 | $2.08 | $2,912 | 4,733 | Apr 9, 2025 |
| Schimmelpennink Evert B. | President, CEO and Secretary | Option Exercise | 4,200 | $1.04 | $4,368 | 49,200 | Mar 7, 2025 |
| Olsson Shawn | Chief Commercial Officer | Option Exercise | 3,333 | $2.08 | $6,933 | 3,333 | Dec 16, 2024 |
| Schimmelpennink Evert B. | President, CEO and Secretary | Option Exercise | 45,000 | $1.04 | $46,800 | 45,000 | Jul 22, 2024 |
| Chevallard Daniel R. | Chief Financial Officer | Purchase | 3,188 | $15.68 | $49,988 | 3,188 | May 14, 2024 |
| MCCOLLUM JAMES W | — | Purchase | 31,332 | $15.99 | $500,999 | 525,565 | May 13, 2024 |
| RA Capital Nexus Fund II, L.P. | — | Award / Grant | 164,729 | — | — | 164,729 | Mar 21, 2024 |
| MCCOLLUM JAMES W | — | Award / Grant | 16,633 | $15.03 | $249,994 | 494,233 | Mar 21, 2024 |
| Odrich Marc | Chief Medical Officer | Award / Grant | 99,599 | — | — | 99,599 | Mar 21, 2024 |
| Versant Vantage II GP, L.P. | — | Other | 598,203 | — | — | 842,162 | Mar 21, 2024 |
| AKKARAJU SRINIVAS | — | Purchase | 74,464 | $4.07 | $303,068 | 8,109,314 | Apr 12, 2022 |
| Gutry Phil | CHIEF BUSINESS OFFICER | Purchase | 5,000 | $4.01 | $20,050 | 299,941 | Apr 11, 2022 |
| AKKARAJU SRINIVAS | — | Purchase | 100,000 | $8.99 | $899,000 | 8,011,850 | Jan 24, 2022 |
| AKKARAJU SRINIVAS | — | Purchase | 43,105 | $8.92 | $384,497 | 7,911,850 | Jan 19, 2022 |
| Samsara BioCapital, L.P. | — | Purchase | 22,329 | $10.19 | $227,533 | 7,814,180 | Dec 15, 2021 |
| AKKARAJU SRINIVAS | — | Purchase | 201,685 | $10.15 | $2,047,103 | 7,791,851 | Nov 22, 2021 |
| Samsara BioCapital, L.P. | — | Purchase | 45,400 | $13.22 | $600,188 | 7,584,766 | Oct 15, 2021 |
| AKKARAJU SRINIVAS | — | Purchase | 9,021 | $14.94 | $134,774 | 7,464,366 | Oct 6, 2021 |
| AKKARAJU SRINIVAS | — | C | 741,107 | — | — | 6,908,870 | Jun 29, 2021 |
| Lehrer-Graiwer Joshua | PRESIDENT AND CEO | Option Exercise | 374,013 | $0.30 | $112,204 | 1,153,544 | Jun 29, 2021 |
| KARSEN PERRY A | — | C | 8,126 | — | — | 164,034 | Jun 29, 2021 |
| JIMENEZ JOSEPH | — | Option Exercise | 49,876 | $0.30 | $14,963 | 153,815 | Jun 29, 2021 |
| Shah Smital | — | Purchase | 5,882 | $17.00 | $99,994 | 5,882 | Jun 29, 2021 |
| Stultz Katherine V | CHIEF OPERATING OFFICER | C | 8,126 | — | — | 216,020 | Jun 29, 2021 |
| Versant Vantage II GP-GP, LLC | — | C | 12,343,727 | — | — | 14,708,398 | Jun 29, 2021 |
| Jerel Davis | — | C | 1,527,719 | — | — | 1,527,719 | Jun 29, 2021 |
| Gutry Phil | CHIEF BUSINESS OFFICER | Option Exercise | 91,406 | $0.30 | $27,422 | 281,962 | Apr 18, 2021 |